---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006285"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:10:03.311596+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology raises $1.05M in registered direct offering and private placement

## Summary
- Issued 434,784 shares at $2.415/share and warrants for 434,784 shares at $2.29/share.
- Warrants are immediately exercisable for a five-year term; gross proceeds ~$1.05M.
- Offering closed on Feb 13, 2025; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent with 7.5% cash fee and warrants.
- Private placement warrants and underlying shares unregistered, resale registration to be filed.

## SEC filing metadata
- accession: 0001493152-25-006285
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315225006285/0001493152-25-006285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315225006285/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006285
- JSON: https://secwatch.observer/filing/0001493152-25-006285.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.